RFPL3 and non-small cell lung carcinoma: For further validation of the IPO13 role in RFPL3’s nuclear translocation, two different siRNAs targeting IPO13 were transfected to individually suppress the expression of IPO13 in two NSCLC cell lines H1299 and A549.